Logos Global Management LP 13D and 13G filings for NextCure, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-02-14 1:40 pm Sale | 2024-12-31 | 13G | NextCure, Inc. NXTC | Logos Global Management LP | 0 0.000% | -208,333 (Position Closed) | Filing |
| 2024-11-14 6:59 pm Purchase | 2024-09-30 | 13G | NextCure, Inc. NXTC | Logos Global Management LP | 208,333 8.900% | 41,628 (+24.97%) | Filing |
| 2024-04-01 6:34 pm Purchase | 2024-04-01 | 13G | NextCure, Inc. NXTC | Logos Global Management LP | 166,705 7.200% | 166,705 (New Position) | Filing |